Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Brain Behav Immun ; 66: 382-393, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28642092

ABSTRACT

The CC chemokine ligand 17 (CCL17) and its cognate CC chemokine receptor 4 (CCR4) are known to control leukocyte migration, maintenance of TH17 cells, and regulatory T cell (Treg) expansion in vivo. In this study we characterized the expression and functional role of CCL17 in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). Using a CCL17/EGFP reporter mouse model, we could show that CCL17 expression in the CNS can be found in a subset of classical dendritic cells (DCs) that immigrate into the CNS during the effector phase of MOG-induced EAE. CCL17 deficient (CCL17-/-) mice exhibited an ameliorated disease course upon MOG-immunization, associated with reduced immigration of IL-17 producing CD4+ T cells and peripheral DCs into the CNS. CCL17-/- DCs further showed equivalent MHC class II and costimulatory molecule expression and an equivalent capacity to secrete IL-23 and induce myelin-reactive TH17 cells when compared to wildtype DCs. In contrast, their transmigration in an in vitro model of the blood-brain barrier was markedly impaired. In addition, peripheral Treg cells were enhanced in CCL17-/- mice at peak of disease pointing towards an immunoregulatory function of CCL17 in EAE. Our study identifies CCL17 as a unique modulator of EAE pathogenesis regulating DC trafficking as well as peripheral Treg cell expansion in EAE. Thus, CCL17 operates at distinct levels and on different cell subsets during immune response in EAE, a property harboring therapeutic potential for the treatment of CNS autoimmunity.


Subject(s)
Chemokine CCL17/metabolism , Dendritic Cells/metabolism , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Animals , Blood-Brain Barrier/immunology , Blood-Brain Barrier/metabolism , Cell Movement , Chemokine CCL17/genetics , Female , Interleukin-23/metabolism , Mice, Inbred C57BL , Mice, Knockout , Spleen/immunology , Spleen/physiopathology , T-Lymphocytes, Regulatory/metabolism , Th17 Cells/metabolism
2.
Neuron ; 90(4): 795-809, 2016 05 18.
Article in English | MEDLINE | ID: mdl-27133464

ABSTRACT

Endocannabinoids (eCBs) exert major control over neuronal activity by activating cannabinoid receptors (CBRs). The functionality of the eCB system is primarily ascribed to the well-documented retrograde activation of presynaptic CB1Rs. We find that action potential-driven eCB release leads to a long-lasting membrane potential hyperpolarization in hippocampal principal cells that is independent of CB1Rs. The hyperpolarization, which is specific to CA3 and CA2 pyramidal cells (PCs), depends on the activation of neuronal CB2Rs, as shown by a combined pharmacogenetic and immunohistochemical approach. Upon activation, they modulate the activity of the sodium-bicarbonate co-transporter, leading to a hyperpolarization of the neuron. CB2R activation occurred in a purely self-regulatory manner, robustly altered the input/output function of CA3 PCs, and modulated gamma oscillations in vivo. To conclude, we describe a cell type-specific plasticity mechanism in the hippocampus that provides evidence for the neuronal expression of CB2Rs and emphasizes their importance in basic neuronal transmission.


Subject(s)
Endocannabinoids/metabolism , Hippocampus/metabolism , Neuronal Plasticity/physiology , Receptor, Cannabinoid, CB2/metabolism , Synapses/metabolism , Action Potentials/physiology , Animals , Cannabinoid Receptor Modulators/metabolism , Long-Term Synaptic Depression/physiology , Mice , Pyramidal Cells/metabolism , Receptors, Metabotropic Glutamate/metabolism , Synaptic Transmission/physiology
3.
J Basic Clin Physiol Pharmacol ; 27(3): 203-7, 2016 May 01.
Article in English | MEDLINE | ID: mdl-26913456

ABSTRACT

BACKGROUND: It has been shown that the brain regulates bone remodelling through sympathetic and parasympathetic nerve fibres. However, it is unclear if signals from the skeleton also influence brain functions and animal behaviours. METHODS: Bone formation was conditionally disrupted by daily injections of aciclovir (10 mg/kg) to transgenic mice expressing a herpes-simplex-virus thymidine kinase under the control of the osteoblast-specific promoter of the Bglap gene. Behavioural studies were conducted after 10 weeks of treatment. RESULTS: Transgenic mice receiving aciclovir injections showed a reduced number of osteoblasts with a concomitantly reduced trabecular bone volume density, when compared to wild-type controls that were treated identically. The general health of the animals was not severely affected, as indicated by a similar increase in body weight, similar activity profiles and similar social behaviours. However, transgenic mice showed significantly increased despair behaviour and increased adrenal gland weights. CONCLUSIONS: Specific animal behaviours can be modulated by a selective disruption of bone formation. The increased despair behaviour observed in transgenic animals indicates that these animals may be more prone to depression-related phenotypes. These findings are important in the context of the well-established clinical association between depression and reduced bone mass.


Subject(s)
Bone and Bones/physiology , Osteogenesis/physiology , Animals , Cell Differentiation/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic/physiology , Osteoblasts/physiology
5.
J Neurosci ; 35(46): 15240-53, 2015 Nov 18.
Article in English | MEDLINE | ID: mdl-26586813

ABSTRACT

Dendritic voltage-gated ion channels profoundly shape the integrative properties of neuronal dendrites. In epilepsy, numerous changes in dendritic ion channels have been described, all of them due to either their altered transcription or phosphorylation. In pilocarpine-treated chronically epileptic rats, we describe a novel mechanism that causes an increased proximal dendritic persistent Na(+) current (INaP). We demonstrate using a combination of electrophysiology and molecular approaches that the upregulation of dendritic INaP is due to a relief from polyamine-dependent inhibition. The polyamine deficit in hippocampal neurons is likely caused by an upregulation of the degrading enzyme spermidine/spermine acetyltransferase. Multiphoton glutamate uncaging experiments revealed that the increase in dendritic INaP causes augmented dendritic summation of excitatory inputs. These results establish a novel post-transcriptional modification of ion channels in chronic epilepsy and may provide a novel avenue for treatment of temporal lobe epilepsy. SIGNIFICANCE STATEMENT: In this paper, we describe a novel mechanism that causes increased dendritic persistent Na(+) current. We demonstrate using a combination of electrophysiology and molecular approaches that the upregulation of persistent Na(+) currents is due to a relief from polyamine-dependent inhibition. The polyamine deficit in hippocampal neurons is likely caused by an upregulation of the degrading enzyme spermidine/spermine acetyltransferase. Multiphoton glutamate uncaging experiments revealed that the increase in dendritic persistent Na current causes augmented dendritic summation of excitatory inputs. We believe that these results establish a novel post-transcriptional modification of ion channels in chronic epilepsy.


Subject(s)
CA1 Region, Hippocampal/pathology , Dendrites/physiology , Down-Regulation/physiology , Sodium Channels/physiology , Spermine/metabolism , Status Epilepticus/pathology , Action Potentials/drug effects , Action Potentials/genetics , Analysis of Variance , Animals , Dendrites/drug effects , Disease Models, Animal , Down-Regulation/drug effects , Humans , In Vitro Techniques , Male , Muscarinic Agonists/toxicity , Pilocarpine/toxicity , RNA, Messenger/metabolism , Rats , Rats, Wistar , Sodium Channel Blockers/pharmacology , Sodium Channels/drug effects , Statistics, Nonparametric , Status Epilepticus/chemically induced , Synaptophysin/metabolism , Tetrodotoxin/pharmacology , Up-Regulation/drug effects , Up-Regulation/physiology
6.
PLoS One ; 10(9): e0138986, 2015.
Article in English | MEDLINE | ID: mdl-26406232

ABSTRACT

The endocannabinoid system (ECS) is a retrograde messenger system, consisting of lipid signaling molecules that bind to at least two G-protein-coupled receptors, Cannabinoid receptor 1 and 2 (CB1 and 2). As CB2 is primarily expressed on immune cells such as B cells, T cells, macrophages, dendritic cells, and microglia, it is of great interest how CB2 contributes to immune cell development and function in health and disease. Here, understanding the mechanisms of CB2 involvement in immune-cell function as well as the trafficking and regulation of CB2 expressing cells are crucial issues. Up to now, CB2 antibodies produce unclear results, especially those targeting the murine protein. Therefore, we have generated BAC transgenic GFP reporter mice (CB2-GFPTg) to trace CB2 expression in vitro and in situ. Those mice express GFP under the CB2 promoter and display GFP expression paralleling CB2 expression on the transcript level in spleen, thymus and brain tissue. Furthermore, by using fluorescence techniques we show that the major sources for GFP-CB2 expression are B cells in spleen and blood and microglia in the brain. This novel CB2-GFP transgenic reporter mouse line represents a powerful resource to study CB2 expression in different cell types. Furthermore, it could be used for analyzing CB2-mediated mobilization and trafficking of immune cells as well as studying the fate of recruited immune cells in models of acute and chronic inflammation.


Subject(s)
Chromosomes, Artificial, Bacterial/genetics , Green Fluorescent Proteins/metabolism , Mice, Transgenic , Receptor, Cannabinoid, CB2/genetics , Animals , B-Lymphocytes/metabolism , Brain/metabolism , Green Fluorescent Proteins/blood , Green Fluorescent Proteins/genetics , Mice , Promoter Regions, Genetic , Receptor, Cannabinoid, CB2/blood , Receptor, Cannabinoid, CB2/metabolism , Spleen/metabolism , Thymus Gland/metabolism
7.
Cell Mol Neurobiol ; 34(8): 1123-30, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25078755

ABSTRACT

Genetic studies have linked the evolutionary novel, anthropoid primate-specific gene locus G72/G30 in the etiology of schizophrenia and other psychiatric disorders. However, the function of the protein encoded by this locus, LG72, is currently controversially discussed. Some studies have suggested that LG72 binds to and regulates the activity of the peroxisomal enzyme D-amino-acid-oxidase, while others proposed an alternative role of this protein due to its mitochondrial location in vitro. Studies with transgenic mice expressing LG72 further suggested that high levels of LG72 lead to an impairment of mitochondrial functions with a concomitant increase in reactive oxygen species production. In the present study, we now performed extensive interaction analyses and identified the mitochondrial methionine-R-sulfoxide reductase B2 (MSRB2) as a specific interaction partner of LG72. MSRB2 belongs to the MSR protein family and functions in mitochondrial oxidative stress defense. Based on our results, we propose that LG72 is involved in the regulation of mitochondrial oxidative stress.


Subject(s)
Carrier Proteins/metabolism , Methionine Sulfoxide Reductases/metabolism , Mitochondria/metabolism , Transcription Factors/metabolism , Animals , COS Cells , Chlorocebus aethiops , HEK293 Cells , Humans , Intracellular Signaling Peptides and Proteins , Mice , Microfilament Proteins , Protein Binding
8.
Biochem Biophys Res Commun ; 441(4): 815-9, 2013 Nov 29.
Article in English | MEDLINE | ID: mdl-24211574

ABSTRACT

The CRISPR/Cas technology has been successfully used to stimulate the integration of small DNA sequences in a target locus to produce gene mutations. However, many applications require homologous recombination using large gene-targeting constructs. Here we address the potential of CRISPR/Cas-mediated double-strand breaks to enhance the genetic engineering of large target sequences using a construct for "humanizing" the mouse Cnr2 gene locus. We designed a small-guide RNA that directs the induction of double strand breaks by Cas9 in the Cnr2 coding exon. By co-transfection of the CRISPR/Cas system with the 10 kb targeting construct we were able to boost the recombination frequency more than 200-fold from 0.27% to 67%. This simple technology can thus be used for the homologous integration of large gene fragments and should greatly enhance our ability to generate any kind of genetically altered mouse models.


Subject(s)
CRISPR-Cas Systems , DNA Breaks, Double-Stranded , Genetic Engineering/methods , Receptor, Cannabinoid, CB2/genetics , Recombination, Genetic/genetics , Animals , Base Sequence , Exons , Genetic Loci , Humans , Mice , Molecular Sequence Data , RNA/genetics , Transfection
9.
PLoS One ; 8(6): e67131, 2013.
Article in English | MEDLINE | ID: mdl-23805296

ABSTRACT

NMDA receptors are activated after binding of the agonist glutamate to the NR2 subunit along with a co-agonist, either L-glycine or D-serine, to the NR1 subunit. There is substantial evidence to suggest that D-serine is the most relevant co-agonist in forebrain regions and that alterations in D-serine levels contribute to psychiatric disorders. D-serine is produced through isomerization of L-serine by serine racemase (Srr), either in neurons or in astrocytes. It is released by astrocytes by an activity-dependent mechanism involving secretory vesicles. In the present study we generated transgenic mice (SrrTg) expressing serine racemase under a human GFAP promoter. These mice were biochemically and behaviorally analyzed using paradigms of anxiety, depression and cognition. Furthermore, we investigated the behavioral effects of long-term administration of D-serine added to the drinking water. Elevated brain D-serine levels in SrrTg mice resulted in specific behavioral phenotypes in the forced swim, novelty suppression of feeding and olfactory bulbectomy paradigms that are indicative of a reduced proneness towards depression-related behavior. Chronic dietary D-serine supplement mimics the depression-related behavioral phenotype observed in SrrTg mice. Our results suggest that D-serine supplementation may improve mood disorders.


Subject(s)
Anxiety Disorders/drug therapy , Anxiety Disorders/metabolism , Behavior, Animal/drug effects , Depression/drug therapy , Depression/metabolism , Serine , Animals , Anxiety Disorders/genetics , Anxiety Disorders/pathology , Depression/genetics , Depression/pathology , Disease Models, Animal , Glial Fibrillary Acidic Protein/genetics , Humans , Mice , Mice, Transgenic , Promoter Regions, Genetic , Racemases and Epimerases/genetics , Racemases and Epimerases/metabolism , Serine/pharmacokinetics , Serine/pharmacology
10.
Neurosci Biobehav Rev ; 37(10 Pt 1): 2410-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23092656

ABSTRACT

Schizophrenia is a human mental disorder that affects an individual's thoughts, perception, affect and behavior, which is caused by a complex interaction of genetic and environmental factors. Genetic studies have implicated the evolutionary novel, anthropoid primate-specific gene locus G72/G30 in the etiology of schizophrenia and other psychiatric disorders. This gene encodes the protein LG72, which has been discussed as a modulator of the peroxisomal enzyme d-amino-acid-oxidase (DAO), or, alternatively as a mitochondrial protein. Recently, G72 transgenic (G72Tg) mice were generated that express the protein throughout the brain. These mice show several behavioral deficits that are related to schizophrenia. Further, G72Tg mice have a reduced activity of mitochondrial complex I, with a concomitantly increased production of reactive oxygen species, as well as deficits in short-term plasticity. Results from these studies demonstrate that expression of the human G72/G30 gene locus in mice produces behavioral phenotypes that are relevant to schizophrenia. They implicate LG72-induced mitochondrial and synaptic defects as a possible pathomechanism of this disease.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/physiology , Schizophrenia/genetics , Schizophrenia/physiopathology , Animals , Behavior, Animal/physiology , Brain/metabolism , Brain/physiology , Electron Transport Complex I/deficiency , Electron Transport Complex I/genetics , Humans , Intracellular Signaling Peptides and Proteins , Mice , Mice, Transgenic , Mitochondrial Diseases/genetics , Neuronal Plasticity/genetics
11.
Proc Natl Acad Sci U S A ; 109(10): 3897-902, 2012 Mar 06.
Article in English | MEDLINE | ID: mdl-22355103

ABSTRACT

Dendritic cells (DCs) are pivotal for the development of experimental autoimmune encephalomyelitis (EAE). However, the mechanisms by which they control disease remain to be determined. This study demonstrates that expression of CC chemokine receptor 4 (CCR4) by DCs is required for EAE induction. CCR4(-/-) mice presented enhanced resistance to EAE associated with a reduction in IL-23 and GM-CSF expression in the CNS. Restoring CCR4 on myeloid cells in bone marrow chimeras or intracerebral microinjection of CCR4-competent DCs, but not macrophages, restored EAE in CCR4(-/-) mice, indicating that CCR4(+) DCs are cellular mediators of EAE development. Mechanistically, CCR4(-/-) DCs were less efficient in GM-CSF and IL-23 production and also T(H)-17 maintenance. Intraspinal IL-23 reconstitution restored EAE in CCR4(-/-) mice, whereas intracerebral inoculation using IL-23(-/-) DCs or GM-CSF(-/-) DCs failed to induce disease. Thus, CCR4-dependent GM-CSF production in DCs required for IL-23 release in these cells is a major component in the development of EAE. Our study identified a unique role for CCR4 in regulating DC function in EAE, harboring therapeutic potential for the treatment of CNS autoimmunity by targeting CCR4 on this specific cell type.


Subject(s)
Dendritic Cells/cytology , Encephalomyelitis, Autoimmune, Experimental/immunology , Gene Expression Regulation , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Interleukin-23/metabolism , Receptors, CCR4/physiology , Animals , Bone Marrow Cells/cytology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Inflammation , Ligands , Macrophages/cytology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Models, Biological , Receptors, CCR4/metabolism
12.
Neuropsychopharmacology ; 36(11): 2233-43, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21716263

ABSTRACT

Genetic studies have implicated the evolutionary novel, anthropoid primate-specific gene locus G72/G30 in psychiatric diseases. This gene encodes the protein LG72 that has been discussed to function as a putative activator of the peroxisomal enzyme D-amino-acid-oxidase (DAO) and as a mitochondrial protein. We recently generated 'humanized' bacterial artificial chromosome transgenic mice (G72Tg) expressing G72 transcripts in cells throughout the brain. These mice exhibit several behavioral phenotypes related to psychiatric diseases. Here we show that G72Tg mice have a reduced activity of mitochondrial complex I, with a concomitantly increased production of reactive oxygen species. Affected neurons display deficits in short-term plasticity and an impaired capability to sustain synaptic activity. These deficits lead to an impairment in spatial memory, which can be rescued by pharmacological treatment with the glutathione precursor N-acetyl cysteine. Our results implicate LG72-induced mitochondrial and synaptic defects as a possible pathomechanism of psychiatric disorders.


Subject(s)
Acetylcysteine/therapeutic use , Carrier Proteins/biosynthesis , Cognition Disorders/drug therapy , Electron Transport Complex I/genetics , Mitochondrial Diseases/genetics , Animals , Carrier Proteins/genetics , Cognition Disorders/enzymology , Cognition Disorders/genetics , Humans , Intracellular Signaling Peptides and Proteins , Male , Mice , Mice, Transgenic , Mitochondrial Diseases/enzymology , Mitochondrial Diseases/pathology , Reactive Oxygen Species/metabolism , Treatment Outcome
13.
Biol Psychiatry ; 67(12): 1205-11, 2010 Jun 15.
Article in English | MEDLINE | ID: mdl-20303474

ABSTRACT

BACKGROUND: The N-methyl-D-aspartate receptor (NMDAR) is critical for learning-related synaptic plasticity in amygdala and hippocampus. As a consequence, there is considerable interest in drugs targeting this receptor to help enhance amygdala- and hippocampus-dependent learning. A promising candidate in this respect is the NMDAR glycine-binding site partial agonist D-cycloserine (DCS). Accumulating clinical evidence indicates the efficacy of DCS in the facilitation of amygdala-dependent fear extinction learning in patients with phobic, social anxiety, panic, and obsessive-compulsive disorder. An important unresolved question though is whether the use of DCS can also facilitate hippocampus-dependent declarative learning in healthy people as opposed to being restricted to the fear memory domain. METHODS: In the present study, we investigated whether or not DCS can facilitate hippocampus-dependent declarative learning. We have therefore combined functional magnetic resonance imaging with two different declarative learning tasks and cytoarchitectonic probabilistic mapping of the hippocampus and its major subdivisions in 40 healthy volunteers administered either a 250 mg single oral dose of DCS or a placebo. RESULTS: We found that DCS facilitates declarative learning as well as blood-oxygen level dependent activity levels in the probabilistically defined cornu ammonis region of the hippocampus. The absence of activity changes in visual control areas underscores the specific action of DCS in the hippocampal cornu ammonis region. CONCLUSIONS: Our findings highlight NMDAR glycine-binding site partial agonism as a promising pharmacological mechanism for facilitating declarative learning in healthy people.


Subject(s)
Cycloserine/pharmacology , Hippocampus/drug effects , Learning/drug effects , Psychomotor Performance/drug effects , Receptors, N-Methyl-D-Aspartate/agonists , Adult , Female , Hippocampus/physiology , Humans , Learning/physiology , Magnetic Resonance Imaging/methods , Male , Photic Stimulation/methods , Psychomotor Performance/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...